New Omega-3 pill could boost heart health better than standard fish oil
NCT ID NCT07394517
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a new omega-3 supplement called Ruby-O, made from phospholipids, raises omega-3 levels in the blood more effectively than standard omega-3 supplements. About 105 adults with mixed dyslipidemia (abnormal blood fats) who are already on statin therapy will take one of three supplements daily for 24 weeks. The main goal is to measure changes in the Omega-3 Index, a marker of heart health.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Phospholipid omega-3 supplement (Ruby-O) and conventional triglyceride omega-3 supplement
What this could lead to
If successful, this could show that a new form of omega-3 supplement raises omega-3 levels in the blood better than standard supplements, potentially improving heart health.
What could go wrong
This is an early-stage trial with only 105 participants, so results may not apply to everyone. The supplement may not significantly outperform the standard version, and individual results vary.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIXED DYSLIPIDEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fundación del Caribe para la Investigación Biomédica (Fundación BIOS)
Barranquilla, Atlántico, 080020, Colombia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact